Skip to content
Independent information service for Miami, not a clinicNo medical advice and no promised resultsA price appears only with its date and its sourceWaitlist open, no partner clinic yet
Exosome Therapy Miami
ENES
Join waitlist
Menu

Home / Microneedling with exosomes in Miami

Microneedling With Exosomes in Miami: Who Does It and What to Ask

Microneedling with exosomes in Miami means two steps in one visit: a device with fine needles makes tiny channels in the skin, then a product containing exosomes is applied. Who does the needling, with which device and which product, matters more than the name on the menu. No exosome product is FDA approved.

Last reviewed:

How the two steps fit together

First a device with fine needles makes tiny channels in the skin. Then a product containing exosomes is applied to the treated area. Microneedling is used on its own to stimulate collagen (2021 safety review, PubMed (PMID 34448760)), and the eight studies of the combination in the 2026 review are small, with 3 to 60 participants each (2026 review, PubMed (PMID 42027180)). A result after a combined visit therefore cannot show which step did what.

Who should be doing the needling

In Florida, the Department of Health licenses health care practitioners, and the license a person holds, plus any supervision, shapes what that person may do. We do not tell you what a given license allows. Ask the clinic to say in writing who will treat you, which license that person holds and who supervises. Then look the person up in the Florida Department of Health license lookup.

The device

Ask for the device name and whether the needle tip or cartridge is sterile, single-use and opened in front of you. Ask how deep the needles go on your skin and why.

The product

Ask for the product name, the maker and the paperwork. No exosome product is FDA approved, and the FDA tells patients to ask whether the FDA has reviewed the treatment (FDA public safety notification, December 6, 2019 (checked October 15, 2026; the page is dated 2019)).

What the evidence says about risks

The most common effects reported after microneedling are short-lived: redness, swelling, pain and dry skin, usually lasting up to 7 days. Lasting dark patches, tram-track scarring and granulomatous reactions have also been reported. Active infection, darker skin and metal allergies raise the risk, and the authors advise caution when microneedling is used with products not approved for intradermal use. 2021 safety review, PubMed (PMID 34448760).

For the combination with exosomes, the 2026 review says more evidence is needed before the safety profile can be known. 2026 review, PubMed (PMID 42027180).

Questions about this combination

Which step produces the result, the needling or the exosomes?

Studies of the combination are small, so a result after a combined visit cannot tell you which step did what.

Can I ask to see the product packaging?

Yes. Ask to see the label or the maker's document before the session, and ask for a photo of it for your records.

Where do I report a problem after a session?

Tell the clinic first. The FDA also asks patients and professionals to report adverse events related to exosome products to FDA MedWatch.

The full list of questions to ask is on the home page.

This page has not yet been reviewed by a licensed clinician. Sources are listed below. Last editorial check: October 15, 2026.

Sources

  1. 2026 review, PubMed (PMID 42027180)
  2. 2021 safety review, PubMed (PMID 34448760)
  3. FDA public safety notification, December 6, 2019 (checked October 15, 2026; the page is dated 2019)
  4. Florida Department of Health license lookup